Mene Pangalos, AstraZeneca R&D chief (AstraZeneca via YouTube)
April 26, 2021 06:27 AM EDTUpdated 07:50 AM
R&D

As­traZeneca and Sanofi tout break­through in €645M al­liance against lead­ing cause of in­fant death

Jason Mast

Editor

Af­ter 23 years, a new treat­ment for one of the lead­ing caus­es of in­fant death may be on the hori­zon.

As­traZeneca and Sanofi an­nounced Mon­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times